Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MYOV - Myovant Sciences: More Than Meets The Eye

MYOV - Myovant Sciences: More Than Meets The Eye

Myovant Sciences Ltd.
  • As you know, Myovant's shares recently tumbled due to ambiguous Phase 3 data release for its prostate cancer franchise.
  • Upon closer inspection, I believe that relugolix will ultimately be FDA-approved for prostate cancer.
  • I expect relugolix to be FDA-approved for all big three indications.

For further details see:

Myovant Sciences: More Than Meets The Eye
Stock Information
Company Name: Myovant Sciences Ltd.
Stock Symbol: MYOV
Market: NYSE
Website: myovant.com
Menu
MYOV MYOV Quote MYOV Short MYOV News MYOV Articles MYOV Message Board
Get MYOV Alerts

News, Short Squeeze, Breakout and More Instantly...